![Gustav Gaudernack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gustav Gaudernack
No open positions remaining
Health Technology
Profile
Gustav Gaudernack is the founder of Circio Holding ASA, which was founded in 2010.
Currently, he is the Chief Scientific Officer at Ultimovacs ASA. Previously, he worked as a Professor at Norwegian Radium Hospital from 1995 to 2011.
Former positions of Gustav Gaudernack
| Companies | Position | End |
|---|---|---|
Norwegian Radium Hospital | Corporate Officer/Principal | 01/01/2011 |
Ultimovacs ASA
 Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Chief Tech/Sci/R&D Officer | - |
| CIRCIO HOLDING ASA | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Norwegian Radium Hospital |
- Stock Market
- Insiders
- Gustav Gaudernack
